AlphaCrest Capital Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,630
Closed -$3.22M 536
2022
Q3
$3.22M Buy
6,630
+2,620
+65% +$1.27M 0.2% 80
2022
Q2
$1.88M Buy
4,010
+1,507
+60% +$671K 0.09% 347
2022
Q1
$1.09M Sell
2,503
-16,799
-87% -$7.03M 0.06% 510
2021
Q4
$8.95M Buy
19,302
+8,562
+80% +$3.79M 0.33% 34
2021
Q3
$4.18M Sell
10,740
-5,685
-35% -$2.41M 0.22% 87
2021
Q2
$7.27M Buy
16,425
+10,517
+178% +$4.59M 0.31% 49
2021
Q1
$2.48M Buy
5,908
+1,874
+46% +$748K 0.14% 196
2020
Q4
$1.66M Buy
4,034
+1,665
+70% +$692K 0.14% 180
2020
Q3
$981K Buy
2,369
+852
+56% +$343K 0.11% 267
2020
Q2
$588K Sell
1,517
-166
-10% -$62.1K 0.1% 320
2020
Q1
$528K Sell
1,683
-3,223
-66% -$1.09M 0.06% 545
2019
Q4
$1.8M Sell
4,906
-18,772
-79% -$5.95M 0.15% 137
2019
Q3
$6.05M Buy
23,678
+22,483
+1,881% +$6.3M 0.37% 19
2019
Q2
$317K Sell
1,195
-4,205
-78% -$1.07M 0.03% 847
2019
Q1
$1.44M Buy
5,400
+1,775
+49% +$512K 0.22% 101
2018
Q4
$1.04M Buy
+3,625
New +$1.15M 0.31% 56

Other funds holding HUM

AlphaCrest Capital Management's HUM Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Humana (HUM) in Q4 2022, closing a stake of 6,630 shares — an estimated $3.22M sold.

AlphaCrest Capital Management first reported a position in HUM in Q4 2018 and held it in 16 quarters. The position peaked at $8.95M in Q4 2021. 1,078 funds tracked by Wall St. Rank hold HUM as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Humana position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 6,630 Humana shares in Q4 2022, an estimated $3.22M.
  • AlphaCrest Capital Management first reported a position in Humana in Q4 2018 and held it in 16 quarters.
  • AlphaCrest Capital Management's Humana position peaked at $8.95M in Q4 2021.
  • 1,078 funds tracked by Wall St. Rank held Humana as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.